Quicklook

1) Cost

2) Expantion in yhe contrys.

Risk/Mitigation

1) Obsolete Technology.

2) Entry of new technology.

Description

1) Chemical diagnostic.

2) Not requiere the use of chemical reagents

Status

1) Prototype.

2) Patent proof.

Features.

1) Use of the fiber optic core enhances.

2) The tube can allow for an automated.

3) The tube allows for the potential for real time

Pain

1) Enhances accuracy of the analysis

2) Requies a much smaller hood scimple from the patient.

3) The key indicator of renal failurz.

4) Is fast and accurate.

5) Tretament dialysis.

Interest

1) Centralized laboraories.

2) In hospital laboratories.

3) Government laboratories.

4) Veterinary offices.

Selection.

1) Boston University Medical Center.

2) Austin Regional Clinics Lab Facilities.

Characteristics

2) EE.UU Laboratories

1) Private and public hospitals.

Subtema

Customer Value poposition

Roman is still expensive.

It is stuck at price and speedbuel.

Market can be $100-$300 mill.

Seller value proposition

$200.00 but used reforbished machines are
aviable $9,995.$20,000

Blood work cost 20-30

Direct competiton.

Projection

Rapidly enough.

Insura implication.

Equipament buying tends.

Interface to apropriate diagnostic.

Recomendation.

Measonng.

Information.

Perception

Ensure.

Projection.

Subtema

Market.

Direct NO COMPETITION

Indirect: RxIS
Beckman/Cauter.

Future

New.

Joe Skraba vice president
of business developmen of lab now.

Existing.

R x IS

Beckman/

Coulter.

Technical.

Dinner.

Wokkforce.

Technology.

Core Activities

The cost saving to the lab will need to be
proven.

Creating a prototype .

Pilot testing.

Business Model

Canvas

Intellectual property proyetion

Sustentability

It is limited because Roman
is still expensive.

Barries.

Actting FDA approvalon to commercialization.

Approrals from the clinval lateratery imparemen amendments (LIA).

Federal agency that insprets medical laboratories.

Ama review and stablishment of rembarsement processes

Risk / Mitigation.

Raman net surtable for poin up care measurements.

Errorous results

Freedom to aperate.

Mostly local.

Priorant

Not new technology.

First to file

The liquid core optical fiber LCOF

Landscape

Opportunity for expansion and innovation.

Patents

Prototype, patent proof.

Novelty

Technique lends itself toan automated